1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 4:Frequency of clinically meaningful changes in BT-RADS scores in 45 patients following the inclusion of perfusion metrics compared with conventional CE-MR imaging alonea
More Experienced Less Experienced Rater 1 Rater 2 Rater 3 Rater 4 CE-MR imaging + ASL-CBF 5 (11%) 7 (16%) 1 (2%) 7 (16%) CE-MR imaging + DSC-rCBV 5 (11%) 4 (9%) 2 (4%) 8 (18%) CE-MR imaging + DSC-FTB 8 (18%) 6 (13%) 3 (7%) 9 (20%)
↵a No significance was found among ASL-CBF, DSC-rCBV, and DSC-FTB when added to CE-MR imaging with respect to the number of clinically meaningful score changes (P = .53). Percentages are in parentheses.